ADC Therapeutics SA (ADCT)
4.91
+0.18
(+3.81%)
USD |
NYSE |
May 03, 13:44
ADC Therapeutics Gross Profit (TTM): 67.03M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 67.03M |
| September 30, 2023 | 121.08M |
| June 30, 2023 | 181.98M |
| March 31, 2023 | 179.04M |
| December 31, 2022 | 206.61M |
| September 30, 2022 | 152.26M |
| Date | Value |
|---|---|
| June 30, 2022 | 89.88M |
| March 31, 2022 | 78.49M |
| December 31, 2021 | 32.52M |
| September 30, 2021 | 16.28M |
| June 30, 2021 | 3.639M |
| March 31, 2021 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Mar 2021
206.61M
Maximum
Dec 2022
94.07M
Average
84.19M
Median
Gross Profit (TTM) Benchmarks
| Roche Holding AG | 49.38B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | 239.75M |
| Addex Therapeutics Ltd | -- |
| NLS Pharmaceutics Ltd | -- |